Oncolytics Biotech Inc. Raises C$25 Million For Cancer Trial

TORONTO, Oct 28 (Reuters) - Oncolytics Biotech (ONC.TO) stock dropped 9 percent on Thursday on news the company will issue new shares in a bought deal to raise at least C$25 million ($24.4 million) to help fund an ongoing cancer treatment trial.